000 01273 a2200337 4500
005 20250516191308.0
264 0 _c20141114
008 201411s 0 0 eng d
022 _a1538-7836
024 7 _a10.1111/jth.12504
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGaboreau, Y
245 0 0 _aThe predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study: comment.
_h[electronic resource]
260 _bJournal of thrombosis and haemostasis : JTH
_c2014
300 _a421-3 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Comment
650 0 4 _aAtrial Fibrillation
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aVenous Thromboembolism
_xblood
650 0 4 _aVitamin K
_xantagonists & inhibitors
700 1 _aLebelhomme, A
700 1 _aSoave, C
700 1 _aImbert, P
700 1 _aCouturier, P
700 1 _aBosson, J L
700 1 _aPernod, G
773 0 _tJournal of thrombosis and haemostasis : JTH
_gvol. 12
_gno. 3
_gp. 421-3
856 4 0 _uhttps://doi.org/10.1111/jth.12504
_zAvailable from publisher's website
999 _c23431357
_d23431357